This Million Targets Drug: A $7M Bet on a CNS Breakthrough
A focused look at a $7 million wager on a CNS drug maker in Phase 3. Learn what this move signals about biotech momen...
Learn about ways to make money delivering food. Flexible earning opportunities await you!
16,083 articlesA focused look at a $7 million wager on a CNS drug maker in Phase 3. Learn what this move signals about biotech momen...
Federal rules demanding domestic-made materials for affordable housing funded with federal dollars are slowing projec...
Investors are watching Bullish (BLSH) as Q1 2026 results set the tone for the year. This guide breaks down the earnin...
A Chinese AI lab is expanding from powering coding assistants to owning the entire toolchain. This move could reshape...
The Janus Henderson AAA CLO ETF draws buyers with a high yield and AAA label, but a hidden tail-risk dynamic could er...
A stock with an eye popping yield can grab attention fast. But does the income last as the business navigates headwin...
SpaceX begins trading on Nasdaq, positioning Elon Musk for trillionaire status as investors bet on a bold, multi-plan...
When the Fed signals a path to price stability, Bitcoin often takes a hit before buyers step in. This article breaks ...
Two senior DeepMind researchers left within 48 hours, jolting Alphabet's AI strategy and sending shockwaves through t...
Two global asset managers, two different paths to growth. This analysis pits BlackRock and Invesco against each other...
As the market wrestles with SaaS cycles and AI disruption fears, monday.com stock has seen its share of monday blues....
Berkshire Hathaway is changing under Greg Abel, shifting toward concentrated bets on Apple and Alphabet. This article...